Lungnakrabba verður staðfest við eini røð av kanningum og kanningarháttum, sum kunnu vera:
1. Sjúkueyðkenni og kanning: Læknin spyr um tínar sjúkueyðkenni, um tú hevur roykt og um tað er nøkur í familjuni, sum hevur havt lungnakrabba.
Eisini skal tú verða kannað fyri sjúkueyðkenni.
2. Myndatøku kanningar: Røntgenmyndir av bróstkassanum og CT-skanningar verða vanliga nýttar til at gera nágreiniligar myndir av lungunum og rundan um lungini.
Hesar kanningar kunnu vera við til at finna fram til sjúkueyðkenni, sum til dømis vøkstur ella knobbar, sum kunnu benda á lungnakrabba.
3. Sputumcytologi: Eitt sýni av sputum (slím, sum verður hostað upp úr lungunum) verður kannað við mikroskopi fyri at kanna eftir krabbameinsfrumum.
4. Biopsi: Eitt sýni av lungnavevnaði verður tikið og kannað við mikroskopi fyri at vita, um krabbameinsfrumur eru í.
Hetta kann gerast við at taka lungnabruna, við nálareyðtøku ella við skurðviðgerð.
5. Bronkoskopi: Eitt tunt, upplýst rør við myndatóli verður latið inn gjøgnum nøsina ella munnin og niður í hálsin fyri at kanna andaleiðina og lunguni.
Henda mannagongdin kann eisini brúkast til at taka vevnaðarroyndir til biopsi.
6. Fín-nálaspiración (FNA): Ein tunn náli verður stungin í lungnaknútin ella lungnasamansetingina fyri at taka eina roynd av kyknum til kanningar.
7. Thoracentesis: Við eini nálareyð verður væta tikin úr millumrúminum millum lunguni og bróstvegginum, og síðan verður vætan kannað fyri krabbameinsfrumur.
8. Blóðroyndir: Blóðroyndir einsamallar kunnu ikki staðfesta lungnakrabba, men tær kunnu hjálpa til at kanna heilsustøðuna hjá sjúklinginum og finna fram til, um okkurt er, sum bendir á, at hann hevur krabbamein.
9. Bein-skanning, MR-skanning, PET-skanning og aðrar kanningar: Hesar kanningarnar kunnu verða brúktar til at kanna, um krabbamein hevur breitt seg til onnur likamspartar.
Tá ið lungnakrabba er staðfest, kunnu fleiri kanningar gerast fyri at staðfesta, hvussu langt sjúkan er komin.
Hesar kanningar kunnu fevna um fleiri myndatøku kanningar, so sum CT-skanning av heilanum, bein-skanning ella positron-emission tomografi (PET) skanning.
Zhou P, Lu F, Wang J, Wang K, Liu B, Li N, Tang B: A portable point-of-care testing system to diagnose lung cancer through the detection of exosomal miRNA in urine and saliva. Chem Commun (Camb). 2020, 56 (63): 8968-8971.
Ni J, Guo Z, Zhang L: [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients]. Zhonghua Nei Ke Za Zhi. 2016, 55 (1): 25-30.
Nishiyama N, Nakatani S, Iwasa R, Taguchi S, Inoue K, Kinoshita H: [Differential diagnosis between peripheral lung cancer invading the chest wall and chest-wall tumors]. Kyobu Geka. 1997, 50 (10): 893-7.
Kang C, Wang D, Zhang X, Wang L, Wang F, Chen J: Construction and Validation of a Lung Cancer Diagnostic Model Based on 6-Gene Methylation Frequency in Blood, Clinical Features, and Serum Tumor Markers. Comput Math Methods Med. 2021, 2021 (): 9987067.
Heydari F, Rafsanjani MK: A Review on Lung Cancer Diagnosis Using Data Mining Algorithms. Curr Med Imaging. 2021, 17 (1): 16-26.
Li L, Feng T, Zhang W, Gao S, Wang R, Lv W, Zhu T, Yu H, Qian B: MicroRNA Biomarker hsa-miR-195-5p for Detecting the Risk of Lung Cancer. Int J Genomics. 2020, 2020 (): 7415909.
Li B, Yuan Q, Zou YT, Su T, Lin Q, Zhang YQ, Shi WQ, Liang RB, Ge QM, Li QY, Shao Y: CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis. J Cancer. 2020, 11 (10): 2730-2736.
Magee ND, Villaumie JS, Marple ET, Ennis M, Elborn JS, McGarvey JJ: Ex vivo diagnosis of lung cancer using a Raman miniprobe. J Phys Chem B. 2009, 113 (23): 8137-41.
['Avsakan: sjúkuviðurskifti']
['Henda heimasíðan er bert til undirvísingar og kunningar og er ikki ætlað sum læknalig ráðgeving ella faklig tænasta.']
['Upplýsingarnar eiga ikki at verða nýttar til at staðfesta ella viðgera nakran heilsutrupulleika ella sjúku, og tey, sum ynskja persónliga læknahjálp, eiga at venda sær til ein autoriseraðan lækna.']
['Gev gætur, at tað neuronala netið, sum gevur svar uppá spurningarnar, er serliga skeivt, tá ið talan er um talgilda innihaldið, t.d. talið av fólki, sum hava fingið staðfest eina ávísa sjúku.']
['Spyr altíð læknan ella annan skikkaðan heilsuhjálpara um ráðgeving í sambandi við sjúku. Vanvirð ongantíð professionella læknaráðgeving ella drála við at leita eftir henni vegna okkurt, tú hevur lisið á hesi heimasíðu.']
['Avsakan: upphavsrættur']
['Digital Millennium Copyright Act frá 1998, 17 U.S.C. § 512 (DMCA) gevur rætt til at kæra til rættindahavarar, sum halda, at tilfar, sum kemur á internetið, brýtur teirra rættindi sambært amerikanskum lógum um upphavsrætt. ']
['Um tú í góðari trúgv heldur, at eitthvørt innihald ella tilfar, sum er gjørt tøkt í sambandi við okkara heimasíðu ella tænastur, brýtur tíni upphavsrættindi, kanst tú (ella tín umboðsmaður) senda okkum eina fráboðan, har tú biður um, at innihaldið ella tilfarið verður tikið burtur ella atgongdin til tað verður sperrað.']
['Tilmeldingarnar skulu verða skrivligar við telduposti (sí "Kontakt" fyri teldupostadressu).']
['DMCA krevur, at fráboðan um meint brot á upphavsrættin skal innihalda hesar upplýsingar: (1) lýsing av tí upphavsrættarliga verkinum, sum talan er um, (2) lýsing av tí meinta brot á upphavsrættin og upplýsingar, sum eru nøktandi til at vit kunnu finna innihaldið (3) upplýsingar um teg, t.d. tín bústað, telefonnummar og teldupostbústað (4) eina váttan frá tær um, at tú í góðari trúgv heldur, at innihaldið, sum tú klagar um, ikki er loyvt av rættindahavanum ella umboði hansara ella sambært lóggávu']
['5) eina váttan frá tær, undirskrivað undir revsing fyri lygi, um, at upplýsingarnar í fráboðanini eru rættar, og at tú hevur heimild at gera galdandi upphavsrættin, sum verður hildin at vera brotin,']
['og 6) fysiska ella elektroniska undirskrift hjá rættindahavara ella persóni, sum hevur loyvi at virka fyri rættindahavara.']
['Um tú ikki hevur upplýst allar omanfyri nevndu upplýsingar, kann tað hava við sær, at viðgerðin av klaguni verður seinkað.']
['Set teg í samband við']
['Vinarliga send okkum ein teldupost við einum hvørjum spurningi/uppskoti.']
How is lung cancer diagnosed?
Lung cancer is diagnosed through a combination of tests and procedures, which may include:
1. Medical history and physical examination: The doctor will ask about your symptoms, smoking history, and family history of lung cancer.
They will also perform a physical examination to check for any signs of the disease.
2. Imaging tests: Chest X-rays and computed tomography (CT) scans are commonly used to create detailed images of the lungs and surrounding structures.
These tests can help detect abnormalities, such as tumors or nodules, that may indicate the presence of lung cancer.
3. Sputum cytology: A sample of your sputum (mucus coughed up from the lungs) is examined under a microscope to look for cancer cells.
4. Biopsy: A sample of lung tissue is removed and examined under a microscope to determine if cancer cells are present.
This can be done through a bronchoscopy, needle biopsy, or surgical biopsy.
5. Bronchoscopy: A thin, lighted tube with a camera is inserted through the nose or mouth and down the throat to examine the airways and lungs.
This procedure can also be used to collect tissue samples for biopsy.
6. Fine-needle aspiration (FNA): A thin needle is inserted into the lung nodule or mass to collect a sample of cells for examination.
7. Thoracentesis: Fluid is removed from the space between the lungs and chest wall using a needle, and the fluid is then examined for cancer cells.
8. Blood tests: While blood tests alone cannot diagnose lung cancer, they can help determine the overall health of the patient and identify any abnormalities that may indicate the presence of cancer.
9. Bone scan, mri, pet scan, and other tests: These tests may be used to determine if the cancer has spread to other parts of the body.
Once lung cancer is diagnosed, additional tests may be performed to determine the stage of the cancer, which helps guide treatment decisions.
These tests may include more imaging tests, such as a CT scan of the brain, bone scan, or positron emission tomography (PET) scan.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Umleið']
['BioMedLib nýtir sjálvvirkandi teldur (maskinlæringaralgoritmur) til at gera spurningar og svar.']
['Vit byrja við 35 milliónum av biomedicinskum útgávum frá PubMed/Medline. eisini heimasíðum frá RefinedWeb.']
